Telisotuzumab vedotin (teliso-v) monotherapy in patients with previously treated c-Met+ advanced non-small cell lung cancer.

Camidge, D. RossMoiseenko, FedorCicin, IrfanHorinouchi, HidehitoFilippova, ElenaBar, JairLu, Shun2024-06-122024-06-1220210008-54721538-7445https://hdl.handle.net/20.500.14551/26756Annual Meeting of the American-Association-for-Cancer-Research (AACR) -- APR 10-MAY 21, 2021 -- Philadelphia, PA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Telisotuzumab vedotin (teliso-v) monotherapy in patients with previously treated c-Met+ advanced non-small cell lung cancer.Conference Object8113Q1WOS:000680263501335